信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·港股午评：恒生科技指数跌逾2%药明系重挫2022-2-8 12:14:05
·重磅突发！万亿“宁王”罕见暴跌9%，白酒芯片锂电齐大跌！美国又下黑手？3000亿医药巨头闪崩30%！2022-2-8 12:05:16
·突发！美商务部下黑手，药明生物暴跌30%，药明康德开盘1分钟跌停！来看公司最新回应2022-2-8 11:56:38
·药明系个股重挫、宁德时代大跳水！茅台一度失守1800元大关谁来挺起A股的脊梁？2022-2-8 11:48:43
·药明系个股暴跌，药明康德跳空跌停，港股药明生物最高跌超30%2022-2-8 11:48:01
·药明生物被美国列入“未经核实名单”公司紧急回应2022-2-8 11:31:19
·港股药明生物跌幅扩大至超30%2022-2-8 9:53:55
·香港恒生指数开盘跌0.13%药明生物跌超14%2022-2-8 9:28:40
·最新！机构调研动向大曝光：“宁王”朋友圈最吸睛深跌医药、科技股也获青睐2022-2-8 8:11:07
·艾迪药业3名股东减持914.71万股套现1.54亿2021年公司亏损2200万-3300万2022-2-7 20:44:56
·金鼎医药2021年年度净利564.09万元同比净利减少85.39%2022-2-7 19:33:13
·医药生物行业周报：医药持仓处于历史低位行业迎来配置良机2022-2-7 18:38:01
·东阳光：宜昌东阳光药业所持21,00万股解质押占公司总股本比例0.7%2022-2-7 18:17:24
·医药生物行业2月月报：十四五规划发布聚焦创新驱动和产业链发展2022-2-7 13:45:53
·医药生物行业周报：医药工业“十四五”规划说了什么？兼看调整后的医药资产大梳理2022-2-7 13:41:58
·创新药周报：2022年1月第四周2022-2-7 13:33:15
·港股医药板块开盘即大幅上涨，港股医药ETF涨幅超过5%2022-2-7 11:38:19
·开拓药业涨幅扩大至超30%2022-2-7 11:29:21
·尔康制药最高计提减值9.5亿元致业绩亏损?交易所发函问询计提合理性2022-2-7 9:57:30
·医药行业行业周报：新冠研发持续进展关注疫情防治供应链2022-2-7 8:50:03

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]